Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001575872-25-000580·DR REDDYS LABORATORIES LTD
Schedule 13D ownership disclosure
Dr Reddy's Laboratories Ltd
American depositary shares, each representing one equity share · CUSIP: 256135203
Event date: 2025-09-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- G.V. PrasadReported CIK 0001663911
Shares: 108,813,010.00 · Class: 13.04%
- K. Satish ReddyReported CIK 0001663790
Shares: 113,356,510.00 · Class: 13.58%
- GVP Family TrustReported CIK 0002064996
Shares: 96,095,920.00 · Class: 11.51%
- VSD Family TrustReported CIK 0002060584
Shares: 75,630,620.00 · Class: 9.06%
- G. AnuradhaReported CIK 0002067759
Shares: 96,141,945.00 · Class: 11.52%
- Deepti ReddyReported CIK 0002060570
Shares: 75,656,320.00 · Class: 9.07%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001575872-25-000580
- Form type
- SCHEDULE 13D/A
- Filer
- DR REDDYS LABORATORIES LTD
- CIK
- CIK 1135951
- Filed
- Sep 18, 2025
- Reporting period
- Sep 17, 2025
- Description
- Schedule 13D beneficial ownership